| Active ingredient (INN) | Losartan |
|---|---|
| Therapeutic category | Auto-created by Health Canada — Recalls and Safety Alerts scraper |
| Controlled substance | No |
| Marketing-authorisation holders | ACCORD-UK LIMITED, TEVA UK LIMITED, SANDOZ LIMITED, ROSEMONT PHARMACEUTICALS LIMITED +3 more |
| Registrations on file |
|---|
| 18 |
| Patient information leaflet (PIL) | Not on file |
|---|
| Summary of product characteristics (SPC) | Not on file |
|---|
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Losartan Potassium/Hydrochlorothiazide 50/ | 12.5MG | tablet | 🇬🇧 GB | ACCORD-UK LIMITED | Active |
| Losartan Potassium/Hydrochlorothiazide 100/ | 25MG | tablet | 🇬🇧 GB | ACCORD-UK LIMITED | Active |
| Losartan Potassium/Hydrochlorothiazide | 100MG | tablet | 🇬🇧 GB | ACCORD-UK LIMITED | Active |
| Losartan Potassium | 25MG | tablet | 🇬🇧 GB | TEVA UK LIMITED | Active |
| Losartan Potassium | 50 MG | tablet | 🇬🇧 GB | TEVA UK LIMITED | Active |
| Losartan Potassium | 100MG | tablet | 🇬🇧 GB | TEVA UK LIMITED | Active |
| Losartan Potassium/Hydrochlorothiazide | 100 MG | tablet | 🇬🇧 GB | SANDOZ LIMITED | Active |
| Losartan Potassium | 10MG | solution | 🇬🇧 GB | ROSEMONT PHARMACEUTICALS LIMITED | Active |
| Losartan Potassium/Hydrochlorothiazide | 50MG | tablet | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| Losartan Potassium | 12.5 MG | tablet | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| Losartan Potassium | 25 MG | tablet | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| Losartan Potassium | 100 MG | tablet | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| Losartan Potassium/Hydrochlorothiazide 100/ | 12.5MG | tablet | 🇬🇧 GB | KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO | Active |
| Losartan Potassium/Hydrochlorothiazide | 50 MG | tablet | 🇬🇧 GB | SANDOZ LIMITED | Active |
| Losartan Potassium / Hydrochlorothiazide | 100 MG | tablet | 🇬🇧 GB | SANDOZ LIMITED | Active |